Bio-Rad Laboratories
BIO and BIO.B • NYSE
Bio-Rad Laboratories is a medical - devices company in the healthcare sector trading on NYSE, led by CEO Norman D. Schwartz, with a market cap of $7.2B.
CEONorman D. Schwartz
Next Earnings
Upcoming earnings announcement for Bio-Rad Laboratories
Date
Thursday, April 30, 2026 (in 3 weeks)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
$2.19
Revenue Estimate
$583.6M
Earnings History
Past 12 earnings reports for Bio-Rad Laboratories
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 12, 2026 | Q4 2025 | $2.51Est: $2.65 | -5.3% | $693.2MEst: $689.9M | +0.5% |  10-K |
| Oct 29, 2025 | Q3 2025 | $2.26Est: $2.08 | +8.7% | $653.0MEst: $651.3M | +0.3% | 10-Q |
| Jul 31, 2025 | Q2 2025 | $2.61Est: $1.82 | +43.4% | $651.6MEst: $612.6M | +6.4% | 10-Q |
| May 1, 2025 | Q1 2025 | $2.54Est: $1.78 | +42.7% | $585.4MEst: $573.2M | +2.1% | 10-Q |
| Feb 13, 2025 | Q4 2024 | $2.90Est: $2.88 | +0.7% | $667.5MEst: $679.8M | -1.8% | 10-K |
| Oct 30, 2024 | Q3 2024 | $2.01Est: $1.16 | +73.3% | $649.7MEst: $628.2M | +3.4% | 10-Q |
| Aug 1, 2024 | Q2 2024 | $3.11Est: $2.01 | +54.7% | $638.5MEst: $645.8M | -1.1% | 10-Q |
| May 7, 2024 | Q1 2024 | $2.29Est: $2.15 | +6.5% | $610.8MEst: $619.1M | -1.3% | 10-Q |
| Feb 15, 2024 | Q4 2023 | $3.10Est: $2.82 | +9.9% | $681.2MEst: $685.1M | -0.6% | 10-K |
| Oct 26, 2023 | Q3 2023 | $2.33Est: $2.78 | -16.2% | $632.1MEst: $689.6M | -8.3% | 10-Q |
| Aug 3, 2023 | Q2 2023 | $3.00Est: $2.55 | +17.6% | $681.1MEst: $687.9M | -1.0% | — |
| May 4, 2023 | Q1 2023 | $3.34Est: $3.54 | -5.6% | $676.8MEst: $689.8M | -1.9% | — |